DCF — FREEMAN NEOSHO HOSPITAL
Enterprise Value: $4.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$4.9M
Enterprise Value
$0.6M
PV of Cash Flows
$4.3M
PV of Terminal Value
$7.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $33.9M | $1.3M | 4.0% | $-0.2M | $-0.2M |
| Year 2 | $34.9M | $1.7M | 5.0% | $0.0M | $0.0M |
| Year 3 | $36.0M | $2.1M | 6.0% | $0.3M | $0.2M |
| Year 4 | $37.1M | $2.4M | 6.0% | $0.4M | $0.3M |
| Year 5 | $38.2M | $2.5M | 7.0% | $0.5M | $0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $4.9M. Terminal value accounts for 88% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$32.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.0334282321484285
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5